|View printer-friendly version|
|Array Biopharma to Present at the Bio-Europe 2004 Partnering Conference|
BOULDER, Colo., Oct 21, 2004 /PRNewswire-FirstCall via COMTEX/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Operating Officer and Vice President of Business Development, David L. Snitman, Ph.D., will speak at the BIO-Europe 2004 Partnering Conference on November 9 in Cologne, Germany.
Event: BIO-Europe 2004 Partnering Conference Presenter: David L. Snitman, Ph.D., Chief Operating Officer and Vice President, Business Development, Array BioPharma Date: Tuesday, November 9, 2004 Time: 10:15 am CET Location: Congress Center, Cologne, Germany
About Array BioPharma:
Array BioPharma is a biopharmaceutical company focused on the discovery, development and commercialization of orally active drugs to address significant unmet medical needs. Our proprietary drug development pipeline is primarily focused on the treatment of cancer and inflammatory disease and includes several small molecule drug candidates that are designed to regulate targets in therapeutically important biologic pathways. In addition, leading pharmaceutical and biotechnology companies access our drug discovery technologies and expertise through collaborations to design, create, optimize and evaluate drug candidates across a broad range of therapeutic areas. For more information on Array, please go to www.arraybiopharma.com.
SOURCE Array BioPharma Inc.
Tricia Haugeto of Array BioPharma Inc.,